170 related articles for article (PubMed ID: 2277379)
1. Pancreatic function and gene deletion F508 in cystic fibrosis.
Borgo G; Mastella G; Gasparini P; Zorzanello A; Doro R; Pignatti PF
J Med Genet; 1990 Nov; 27(11):665-9. PubMed ID: 2277379
[TBL] [Abstract][Full Text] [Related]
2. Endocrine and exocrine pancreatic function and the delta F508 mutation in cystic fibrosis.
Lanng S; Schwartz M; Thorsteinsson B; Koch C
Clin Genet; 1991 Nov; 40(5):345-8. PubMed ID: 1756609
[TBL] [Abstract][Full Text] [Related]
3. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of the pancreas in cystic fibrosis.
Durie PR
Neth J Med; 1992 Oct; 41(3-4):97-100. PubMed ID: 1470291
[TBL] [Abstract][Full Text] [Related]
5. The cystic fibrosis gene and relationships to clinical status.
Campbell PW; Phillips JA
Semin Respir Infect; 1992 Sep; 7(3):150-7. PubMed ID: 1475539
[TBL] [Abstract][Full Text] [Related]
6. Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency. An Italian collaborative study.
Ferrari M; Antonelli M; Bellini F; Borgo G; Castiglione O; Curcio L; Dallapiccola B; Devoto M; Estivill X; Gasparini P
Hum Genet; 1990 Apr; 84(5):435-8. PubMed ID: 2323776
[TBL] [Abstract][Full Text] [Related]
7. The deletion F508 is the major gene mutation in a representative Belgian cystic fibrosis population.
Bonduelle M; Lissens W; Malfroot A; Dab I; Liebaers I
Hum Genet; 1990 Sep; 85(4):395-6. PubMed ID: 2210742
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of 16 cystic fibrosis patients with the missense mutation R334W, a pancreatic insufficiency mutation with variable age of onset and interfamilial clinical differences.
Estivill X; Ortigosa L; Pérez-Frias J; Dapena J; Ferrer J; Peña L; Peña L; Llevadot R; Giménez J; Nunes V
Hum Genet; 1995 Mar; 95(3):331-6. PubMed ID: 7868128
[TBL] [Abstract][Full Text] [Related]
9. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
Kerem E; Corey M; Kerem BS; Rommens J; Markiewicz D; Levison H; Tsui LC; Durie P
N Engl J Med; 1990 Nov; 323(22):1517-22. PubMed ID: 2233932
[TBL] [Abstract][Full Text] [Related]
10. [A study evaluating the correlation between the phenotype and genotype among 65 cystic fibrosis patients].
Nowakowska A; Bal J; Obersztyn E; Sands D; Maciejko D; Mazurczak T
Pediatr Pol; 1995 Aug; 70(8):633-8. PubMed ID: 8668363
[TBL] [Abstract][Full Text] [Related]
11. The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype.
Duguépéroux I; De Braekeleer M
Eur Respir J; 2005 Mar; 25(3):468-73. PubMed ID: 15738290
[TBL] [Abstract][Full Text] [Related]
12. Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis.
Santis G; Osborne L; Knight RA; Hodson ME
Lancet; 1990 Jun; 335(8703):1426-9. PubMed ID: 1972211
[TBL] [Abstract][Full Text] [Related]
13. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas.
Ahmed N; Corey M; Forstner G; Zielenski J; Tsui LC; Ellis L; Tullis E; Durie P
Gut; 2003 Aug; 52(8):1159-64. PubMed ID: 12865275
[TBL] [Abstract][Full Text] [Related]
14. Frequency of the delta F508 mutation in a sample of 175 Italian cystic fibrosis patients.
Cremonesi L; Ruocco L; Seia M; Russo S; Giunta A; Ronchetto P; Fenu L; Romano L; Devoto M; Romeo G
Hum Genet; 1990 Sep; 85(4):400-2. PubMed ID: 2210746
[TBL] [Abstract][Full Text] [Related]
15. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
16. Frequency of the F508 deletion in cystic fibrosis patients from the European part of the USSR.
Baranov VS; Ivaschenko TE; Gorbunova VN; Livshitz LA; Venozinskis MT; Gembovskaya SA; Kalinin VN; Romanenko OP; Gembitzkaya TE; Orlov AV
Hum Genet; 1991 May; 87(1):61-4. PubMed ID: 2037283
[TBL] [Abstract][Full Text] [Related]
17. Correlation between genotype and phenotype in patients with cystic fibrosis.
Cystic Fibrosis Genotype-Phenotype Consortium
N Engl J Med; 1993 Oct; 329(18):1308-13. PubMed ID: 8166795
[TBL] [Abstract][Full Text] [Related]
18. The changing face of the exocrine pancreas in cystic fibrosis: pancreatic sufficiency, pancreatitis and genotype.
Walkowiak J; Lisowska A; Blaszczyński M
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):157-60. PubMed ID: 18301292
[TBL] [Abstract][Full Text] [Related]
19. delta F508 deletion in cystic fibrosis in Italian families.
Restagno G; Garnerone S; Gennaro C; Varetto O; Ansaldi N; Castello D; Santini B; Carbonara AO
Hum Genet; 1990 Sep; 85(4):422-3. PubMed ID: 1976596
[TBL] [Abstract][Full Text] [Related]
20. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis.
Kerem BS; Buchanan JA; Durie P; Corey ML; Levison H; Rommens JM; Buchwald M; Tsui LC
Am J Hum Genet; 1989 Jun; 44(6):827-34. PubMed ID: 2567116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
